linezolid: VRE infection – dosing, side effects, evidence A – Evigrade
linezolid
Oxazolidinone antibiotic
ATC code: J01XX08(J01XX08)
Brand names
Zyvox, Zyvoxam, Zyvoxid
Mechanism of action
Binds 23S rRNA of the 50S subunit, blocks initiation complex formation. Active against multidrug-resistant gram-positive pathogens (MRSA, VRE). Reversibly inhibits MAO – serotonin syndrome risk with SSRIs and opioids.
Indications
A
Multidrug-resistant tuberculosis
First line
Linezolid is part of the first-line MDR-TB regimen (BPaL/BPaLM) per 2022: bedaquiline + pretomanid + linezolid +/- moxifloxacin for 6 months. Shortening therapy from 18-24 to 6 months is a major shift in MDR-TB management. Linezolid is started at 600 mg/day and reduced to 300 mg or interrupted for hematologic toxicity.
Therapy is prescribed and monitored by tuberculosis specialists. Peripheral and optic neuropathy are dose- and time-dependent limiters of treatment duration.
Linezolid is one of the first-line therapies for severe MRSA skin and soft tissue infections alongside vancomycin. 2011 includes linezolid in regimens for patients with deep abscesses, necrotizing cellulitis, and infected pressure ulcers. The advantage is 100% oral bioavailability, allowing early IV-to-oral switch. The 2016 Cochrane review showed comparable clinical efficacy with vancomycin and higher microbiological cure rates.
Therapy duration is kept below 28 days without close hematologic monitoring. No dose adjustment is needed in renal impairment; in severe hepatic impairment, the drug is used with caution.
Linezolid is one of two main options for VRE infections alongside daptomycin. 2022 recommends linezolid for VRE-E. faecium bacteremia and urinary tract infections. In endocarditis, high-dose daptomycin with ceftaroline is preferred. The drug is active against both resistance gene types (vanA and vanB), and 100% oral bioavailability simplifies step-down therapy.
For uncomplicated MSSA skin infections in outpatients, linezolid is not prescribed. This expensive reserve antibiotic with a high rate of adverse effects (myelosuppression, neuropathy) is used only when first-line drugs are resistant or intolerable. Prescribing linezolid for a simple furuncle or mild cellulitis is irrational antibiotic use and increases the risk of selecting linezolid-resistant strains.
Take 600 mg twice daily orally or intravenously at 12-hour intervals. Food does not affect oral bioavailability (100%). Step-down therapy starts intravenously, switches to oral at 48-72 hours when the patient is stable, with no dose change.
Dose titration
Course duration by indication: SSTI – 10-14 days; pneumonia – 10-14 days; VRE bacteremia – at least 14 days after a negative culture; MDR-TB – 6 months as part of the BPaL regimen. Courses longer than 28 days require intensified hematologic and neurologic monitoring. No dose adjustment is needed in renal impairment.
Monitoring
Before starting the course, check CBC with platelets and ALT/AST. On day 7-10 and weekly thereafter, repeat CBC in all patients; for courses longer than 14 days, monitoring is mandatory. Platelets below 100 × 10⁹/L are an indication to reduce the dose or interrupt therapy. In patients on long courses (MDR-TB), monthly visual acuity, visual fields, color vision, and tendon reflexes are checked.
Special situations
Before prescribing linezolid, review the full list of concomitant drugs: SSRIs, SNRIs, tricyclics, triptans, methylene blue, pethidine, tramadol, and bupropion all increase serotonin syndrome risk. If the antidepressant cannot be withdrawn, consider alternative therapy (daptomycin for VRE/MRSA). Patient education: tyramine-rich foods (aged cheese, cured meats, soy sauce, fermented drinks) during linezolid therapy can cause hypertensive crisis. Tyramine intake is limited to under 100 mg/day.
Аддитивное серотонинергическое действие через ингибицию МАО + SNRI-эффект .
Safety
Boxed warning
FDA has added a warning about serotonin syndrome with concomitant serotonergic agents. Linezolid is a reversible nonselective MAO inhibitor, and concomitant SSRIs/SNRIs increase the risk of life-threatening serotonin syndrome. Before starting therapy, serotonergic agents are discontinued (SSRIs at least 2 weeks before, fluoxetine 5 weeks before) or linezolid is used only for vital indications with close monitoring. Serotonergic agents are not resumed earlier than 24 hours after the last linezolid dose.
Contraindications
Hypersensitivity to linezolid
Concurrent or within-2-weeks use of MAO inhibitors
Concurrent serotonergic drugs (SSRIs, SNRIs, tricyclics, triptans, pethidine) without compelling need and monitoring
Concurrent sympathomimetics (pseudoephedrine, phenylephrine) and dopaminergic agents
Serious adverse effects
Serotonin syndrome with concurrent serotonergic agents
Severe myelosuppression with courses longer than 28 days
Peripheral and optic neuropathy, often irreversible, with prolonged therapy (more than 28 days)
Lactic acidosis with prolonged use
C. difficile-associated colitis
Common adverse effects
Diarrhea, nausea, headache
Frequently asked
What is linezolid used for?
linezolid is evaluated for the following indications with varying evidence strength: Severe MRSA skin and soft tissue infection (evidence tier A), Vancomycin-resistant Enterococcus infection (evidence tier A), Multidrug-resistant tuberculosis (evidence tier A). See the full indication matrix with dosing and citations above on this page.
What are the side effects of linezolid?
Common side effects of linezolid (≥ 1 in 100): Diarrhea, nausea, headache, Taste disturbance, Mucosal candidiasis, Transient liver transaminase elevation. See the Safety section for uncommon and serious reactions.
Is linezolid safe during pregnancy?
FDA category C. FDA category C. Animal studies at multiples of clinical doses showed embryotoxicity. Human data are limited. In pregnancy linezolid is used only for severe infections when no alternatives exist and the benefit to the mother outweighs the fetal risk. The decision is made jointly with infectious disease specialist and obstetrician.
Is linezolid compatible with breastfeeding?
Linezolid passes into breast milk. Breastfeeding is interrupted during the course; the infant is monitored for signs of myelosuppression in case of incidental exposure.
Who should not take linezolid?
linezolid is contraindicated in: Hypersensitivity to linezolid; Concurrent or within-2-weeks use of MAO inhibitors; Uncontrolled hypertension; Pheochromocytoma, carcinoid syndrome, thyrotoxicosis; Concurrent serotonergic drugs (SSRIs, SNRIs, tricyclics, triptans, pethidine) without compelling need and monitoring. Full list in the Safety section.
Myth: "linezolid is a mild antibiotic with an oral form, can be used for any staph infection". Fact: it is a reserve agent. For infections susceptible to beta-lactams or cephalexin, it should not be used. Selection of linezolid-resistant VRE and MRSA has already been reported.
Myth: "neuropathy resolves after stopping the drug". Fact: peripheral and especially optic neuropathy are often irreversible. Vision or sensation changes warrant immediate discontinuation.
Myth: "the tyramine-restricted diet applies only to MAOIs, not to linezolid". Fact: linezolid is a reversible nonselective MAOI; a tyramine-rich diet in patients with hypertension raises the risk of hypertensive crisis.
Thrombocytopenia and anemia with courses longer than 14 days
Rash, pruritus
Insomnia, dizziness
PregnancyFDA C
FDA category C. Animal studies at multiples of clinical doses showed embryotoxicity. Human data are limited. In pregnancy linezolid is used only for severe infections when no alternatives exist and the benefit to the mother outweighs the fetal risk. The decision is made jointly with infectious disease specialist and obstetrician.
Breastfeeding
Linezolid passes into breast milk. Breastfeeding is interrupted during the course; the infant is monitored for signs of myelosuppression in case of incidental exposure.
Does linezolid carry an FDA boxed warning?
FDA has added a warning about serotonin syndrome with concomitant serotonergic agents. Linezolid is a reversible nonselective MAO inhibitor, and concomitant SSRIs/SNRIs increase the risk of life-threatening serotonin syndrome. Before starting therapy, serotonergic agents are discontinued (SSRIs at least 2 weeks before, fluoxetine 5 weeks before) or linezolid is used only for vital indications with close monitoring. Serotonergic agents are not resumed earlier than 24 hours after the last linezolid dose.
linezolid is a mild antibiotic with an oral form, can be used for any staph infection
it is a reserve agent. For infections susceptible to beta-lactams or cephalexin, it should not be used. Selection of linezolid-resistant VRE and MRSA has already been reported.
neuropathy resolves after stopping the drug
peripheral and especially optic neuropathy are often irreversible. Vision or sensation changes warrant immediate discontinuation.
the tyramine-restricted diet applies only to MAOIs, not to linezolid
linezolid is a reversible nonselective MAOI; a tyramine-rich diet in patients with hypertension raises the risk of hypertensive crisis.